🇺🇸 FDA
Patent

US 8367401

Replication competent hepatitis C virus and methods of use

granted A61KA61K48/00

Quick answer

US patent 8367401 (Replication competent hepatitis C virus and methods of use) held by The Board of Regents of the University of Texas System expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K48/00